-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
ArriVent BioPharma, Inc. quarterly Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2023 to Q2 2024.
- ArriVent BioPharma, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 33.5M shares, a 1575% increase year-over-year.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)